The latest EBIT for GENIL.IS is $2.8B as of June 2026. That compares with $1.7B in the prior-year period — up 68.8% year over year. That is above the sector sector average of $-25M. Investors often review this figure alongside Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, GENIL.IS's EBIT moved from $1.7B to $2.8B — a 68.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.'s operating scale or balance-sheet position.

Against its sector companies, GENIL.IS currently prints $2.8B for EBIT, while the sector average sits near $-25M. That is roughly 11274.7% above the sector mean. Large gaps often invite a closer look at Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.'s growth, margins, and balance sheet.

A EBIT figure of $2.8B for GENIL.IS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.

After noting GENIL.IS's EBIT ($2.8B), review year-over-year change from $1.7B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.